Breathe Well Live Well
|
New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma …
PR Newswire (press release) "This study confirms that, based on pharmacy and medical claims, patients with mild asthma using only an inhaled corticosteroid seem to control their asthma … ICS/LABA combination therapy increases asthma-related pharmacy cost |
View full post on asthma – Google News
|
Cinryze® (C1 esterase inhibitor [human]) Data Presented at 2010 Annual Meeting …
PR Newswire (press release) There can be no assurance that that the data presented during the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) … Cinryze(R) (C1 esterase inhibitor [human]) Data Presented at 2010 Annual … |
View full post on asthma – Google News
|
NexBio Presents Data at ACAAI 2010 Demonstrating Mechanism of Action for …
PR Newswire (press release) NexBio presented nonclinical data at ACAAI 2009 from studies in three animal models of asthma, demonstrating that DAS181 inhibits airway hyperreactivity … |
View full post on asthma – Google News
|
Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the …
PR Newswire (press release) It is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. … |
View full post on asthma – Google News
|
Bronchial Thermoplasty Demonstrates Long-Term Asthma Control in Patients With …
PR Newswire (press release) "It is rewarding to see the important benefits of bronchial thermoplasty persist out to two years in patients with severe asthma studied in the AIR2 Trial," … Asthma surgery offers new treatment option |
View full post on asthma – Google News
|
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African …
PR Newswire (press release) (5) "African Americans are approximately 20 percent more likely to have been diagnosed with asthma in their lifetime compared to Caucasians(6), … |
View full post on asthma – Google News
|
Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical …
PR Newswire (press release) According to IMS Health, a pharmaceutical market research firm, the anti-asthma and chronic obstructive pulmonary disease market in China reached … |
View full post on asthma – Google News
|
'EIB Active™' Campaign Launched to Raise Awareness Among America's Families …
PR Newswire (press release) Although exercise is often the most common cause of asthma symptoms, the shortness of breath, wheezing, coughing, chest tightness, unusual fatigue or … |
View full post on asthma – Google News
|
Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs …
PR Newswire (press release) NASHVILLE, Tenn. and GLEN ROCK, NJ, Oct. 6 /PRNewswire/ — HealthLeaders-InterStudy and Fingertip Formulary find that due to the rising costs of asthma and … |
View full post on asthma – Google News
|
CANADIANS WITH ASTHMA CONSIDER THEIR DISEASE 'WELL CONTROLLED' DESPITE SEVERE …
Canada NewsWire (press release) MONTRÉAL, Oct 5 /CNW/ – A new survey, Asthma Insight and Management in Europe and Canada (EUCAN AIM), reveals that a majority of Canadians with asthma … |
View full post on asthma – Google News